The choroid plexus transcriptome reveals changes in type I and II interferon responses in a mouse model of Alzheimer's disease

Brain, Behavior, and Immunity

Volumn 49, Issue , 2015, Pages 280-292

  Mesquita, Sandro Dá ^a,b   Ferreira, Ana C ^a,b   Gao, Fuying ^c   Coppola, Giovanni ^c   Geschwind, Daniel H ^c   Sousa, João C ^a,b   Correia Neves, Margarida ^a,b   Sousa, Nuno ^a,b   Palha, Joana A ^a,b   Marques, Fernanda ^a,b  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Alzheimer's disease; Cerebrospinal fluid; Choroid plexus; Glial cells; Hippocampus; Interferons; Memory; Neuroinflammation; Transcriptome

Indexed keywords

ALPHA1 INTERFERON; AMYLOID BETA PROTEIN; BETA1 INTERFERON; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON; INTERFERON REGULATORY FACTOR 7; TOLL LIKE RECEPTOR 9; TRANSCRIPTOME;

AGE; AGING; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CHOROID PLEXUS; CONTROLLED STUDY; CYTOKINE RESPONSE; DORSAL HIPPOCAMPUS; DOWN REGULATION; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REGULATORY NETWORK; ICAM1 GENE; IFNA1 GENE; IFNAR1 GENE; IFNB1 GENE; IFNG GENE; IRF7 GENE; MALE; MEMORY DISORDER; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; TLR9 GENE; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE; ANIMAL; C57BL MOUSE; CEREBROSPINAL FLUID; DISEASE MODEL; GENETICS; MAZE TEST; METABOLISM; NERVE CELL; PHYSIOLOGY; PSYCHOLOGY;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ASTROCYTES; CHOROID PLEXUS; DISEASE MODELS, ANIMAL; INTERFERON TYPE I; INTERFERON-GAMMA; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; NEURONS; TRANSCRIPTOME;

EID: 84940599385     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2015.06.008     Document Type: Article

References (46)

1. Akwa Y., Hassett D.E., Eloranta M.L., Sandberg K., Masliah E., Powell H., Whitton J.L., Bloom F.E., Campbell I.L. Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. J. Immunol. 1998, 161:5016-5026.
2. Ballard C., Gauthier S., Corbett A., Brayne C., Aarsland D., Jones E. Alzheimer's disease. Lancet 2011, 377:1019-1031.
3. Baron R., Babcock A.A., Nemirovsky A., Finsen B., Monsonego A. Accelerated microglial pathology is associated with Abeta plaques in mouse models of Alzheimer's disease. Aging Cell 2014, 13:584-595.
4. Baruch K., Schwartz M. CNS-specific T cells shape brain function via the choroid plexus. Brain Behav. Immun. 2013, 34:11-16.
5. Baruch K., Ron-Harel N., Gal H., Deczkowska A., Shifrut E., Ndifon W., Mirlas-Neisberg N., Cardon M., Vaknin I., Cahalon L., Berkutzki T., Mattson M.P., Gomez-Pinilla F., Friedman N., Schwartz M. CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging. Proc. Natl. Acad. Sci. USA 2013, 110:2264-2269.
6. Baruch K., Deczkowska A., David E., Castellano J.M., Miller O., Kertser A., Berkutzki T., Barnett-Itzhaki Z., Bezalel D., Wyss-Coray T., Amit I., Schwartz M. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science 2014, 346:89-93.
7. Beauquis J., Vinuesa A., Pomilio C., Pavia P., Galvan V., Saravia F. Neuronal and glial alterations, increased anxiety, and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer's disease. Hippocampus 2014, 24:257-269.
8. Blasko I., Marx F., Steiner E., Hartmann T., Grubeck-Loebenstein B. TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs. FASEB J. 1999, 13:63-68.
9. Browne T.C., McQuillan K., McManus R.M., O'Reilly J.A., Mills K.H., Lynch M.A. IFN-gamma Production by amyloid beta-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease. J. Immunol. 2013, 190:2241-2251.
10. Carro E., Trejo J.L., Gomez-Isla T., LeRoith D., Torres-Aleman I. Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat. Med. 2002, 8:1390-1397.
11. Carro E., Spuch C., Trejo J.L., Antequera D., Torres-Aleman I. Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth factor I. J. Neurosci. 2005, 25:10884-10893.
12. Coppola G. Designing, performing, and interpreting a microarray-based gene expression study. Methods Mol. Biol. 2011, 793:417-439.
13. Coppola G., Karydas A., Rademakers R., Wang Q., Baker M., Hutton M., Miller B.L., Geschwind D.H. Gene expression study on peripheral blood identifies progranulin mutations. Ann. Neurol. 2008, 64:92-96.
14. Costello D.A., Lynch M.A. Toll-like receptor 3 activation modulates hippocampal network excitability, via glial production of interferon-beta. Hippocampus 2013, 23:696-707.
15. Fu Y., Rusznak Z., Kwok J.B., Kim W.S., Paxinos G. Age-dependent alterations of the hippocampal cell composition and proliferative potential in the hAbetaPPSwInd-J20 mouse. J. Alzheimers Dis. 2014, 41:1177-1192.
16. Ghosh S., Wu M.D., Shaftel S.S., Kyrkanides S., LaFerla F.M., Olschowka J.A., O'Banion M.K. Sustained interleukin-1beta overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model. J. Neurosci. 2013, 33:5053-5064.
17. Gotz J., Chen F., van Dorpe J., Nitsch R.M. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 2001, 293:1491-1495.
18. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
19. He J., Hsuchou H., He Y., Kastin A.J., Wang Y., Pan W. Sleep restriction impairs blood-brain barrier function. J. Neurosci. 2014, 34:14697-14706.
20. Johanson C., McMillan P., Tavares R., Spangenberger A., Duncan J., Silverberg G., Stopa E. Homeostatic capabilities of the choroid plexus epithelium in Alzheimer's disease. Cerebrospinal Fluid Res. 2004, 1:3.
21. Kunis G., Baruch K., Rosenzweig N., Kertser A., Miller O., Berkutzki T., Schwartz M. IFN-gamma-dependent activation of the brain's choroid plexus for CNS immune surveillance and repair. Brain 2013, 136:3427-3440.
22. Lewis J., Dickson D.W., Lin W.L., Chisholm L., Corral A., Jones G., Yen S.H., Sahara N., Skipper L., Yager D., Eckman C., Hardy J., Hutton M., McGowan E. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 2001, 293:1487-1491.
23. Lucin K.M., Wyss-Coray T. Immune activation in brain aging and neurodegeneration: too much or too little?. Neuron 2009, 64:110-122.
24. Marques F., Sousa J.C., Coppola G., Falcao A.M., Rodrigues A.J., Geschwind D.H., Sousa N., Correia-Neves M., Palha J.A. Kinetic profile of the transcriptome changes induced in the choroid plexus by peripheral inflammation. J. Cereb. Blood Flow Metab. 2009, 29:921-932.
25. Marques F., Sousa J.C., Sousa N., Palha J.A. Blood-brain-barriers in aging and in Alzheimer's disease. Mol. Neurodegener. 2013, 8:38.
26. Mastrangelo M.A., Sudol K.L., Narrow W.C., Bowers W.J. Interferon-{gamma} differentially affects Alzheimer's disease pathologies and induces neurogenesis in triple transgenic-AD mice. Am. J. Pathol. 2009, 175:2076-2088.
27. Mazen A.M.M., Hemmasi M., Lewis M.F. In search of power: a statistical power analysis of contemporary research in strategic management. Acad. Manage. Proc. 1985, 1985:30-34.
28. Medeiros R., LaFerla F.M. Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony. Exp. Neurol. 2013, 239:133-138.
29. Mesquita S.D., Ferreira A.C., Falcao A.M., Sousa J.C., Oliveira T.G., Correia-Neves M., Sousa N., Marques F., Palha J.A. Lipocalin 2 modulates the cellular response to amyloid beta. Cell Death Differ. 2014, 21:1588-1599.
30. Monsonego A., Imitola J., Petrovic S., Zota V., Nemirovsky A., Baron R., Fisher Y., Owens T., Weiner H.L. Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 2006, 103:5048-5053.
31. Mucke L., Masliah E., Yu G.Q., Mallory M., Rockenstein E.M., Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K., McConlogue L. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 2000, 20:4050-4058.
32. Palop J.J., Mucke L. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat. Neurosci. 2010, 13:812-818.
33. Palop J.J., Chin J., Roberson E.D., Wang J., Thwin M.T., Bien-Ly N., Yoo J., Ho K.O., Yu G.Q., Kreitzer A., Finkbeiner S., Noebels J.L., Mucke L. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 2007, 55:697-711.
34. Querfurth H.W., LaFerla F.M. Alzheimer's disease. N. Engl. J. Med. 2010, 362:329-344.
35. Roberson E.D., Mucke L. 100years and counting: prospects for defeating Alzheimer's disease. Science 2006, 314:781-784.
36. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 1996, 2:864-870.
37. Scholtzova H., Kascsak R.J., Bates K.A., Boutajangout A., Kerr D.J., Meeker H.C., Mehta P.D., Spinner D.S., Wisniewski T. Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology. J. Neurosci. 2009, 29:1846-1854.
38. Scholtzova H., Chianchiano P., Pan J., Sun Y., Goni F., Mehta P.D., Wisniewski T. Amyloid beta and Tau Alzheimer' disease related pathology is reduced by Toll-like receptor 9 stimulation. Acta Neuropathol. Commun. 2014, 2:101.
39. Serot J.M., Zmudka J., Jouanny P. A possible role for CSF turnover and choroid plexus in the pathogenesis of late onset Alzheimer's disease. J. Alzheimers Dis. 2012, 30:17-26.
40. Sousa J.C., Cardoso I., Marques F., Saraiva M.J., Palha J.A. Transthyretin and Alzheimer's disease: where in the brain?. Neurobiol. Aging 2007, 28:713-718.
41. Taylor J.M., Minter M.R., Newman A.G., Zhang M., Adlard P.A., Crack P.J. Type-1 interferon signaling mediates neuro-inflammatory events in models of Alzheimer's disease. Neurobiol. Aging 2014, 35:1012-1023.
42. Villeda S.A., Luo J., Mosher K.I., Zou B., Britschgi M., Bieri G., Stan T.M., Fainberg N., Ding Z., Eggel A., Lucin K.M., Czirr E., Park J.S., Couillard-Despres S., Aigner L., Li G., Peskind E.R., Kaye J.A., Quinn J.F., Galasko D.R., Xie X.S., Rando T.A., Wyss-Coray T. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 2011, 477:90-94.
43. Wright A.L., Zinn R., Hohensinn B., Konen L.M., Beynon S.B., Tan R.P., Clark I.A., Abdipranoto A., Vissel B. Neuroinflammation and neuronal loss precede Abeta plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease. PLoS ONE 2013, 8:e59586.
44. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat. Med. 2006, 12:1005-1015.
45. Zhang E.E., Kay S.A. Clocks not winding down: unravelling circadian networks. Nat. Rev. Mol. Cell Biol. 2010, 11:764-776.
46. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201.